Amarin Corp Plcuk (AMRN) Treasury Shares (2010 - 2026)
Amarin Corp Plcuk (AMRN) posted quarterly Treasury Shares of $69.0 million for Q1 2026, up 3.92% YoY from $66.4 million in Q1 2025, and up 2.5% sequentially from $67.4 million in Q4 2025.
Amarin Corp Plcuk (AMRN) Treasury Shares (2010 - 2026) Analysis & Trends
Amarin Corp Plcuk has disclosed Treasury Shares across 17 years of filings, most recently posting $69.0 million for Q1 2026.
- In Q1 2026, Treasury Shares rose 3.92% year-over-year to $69.0 million; the TTM figure through Mar 2026 stood at $69.0 million (up 3.92% YoY), while the FY2025 annual figure was $67.4 million, up 3.11% from the prior year.
- Treasury Shares improved to $69.0 million in Q1 2026, from $67.4 million in the prior quarter.
- Over the last five years, Treasury Shares for AMRN reached as high as $16.0 million in Q1 2026 and fell as low as -$13.3 million in Q2 2025.
- The 5-year median for Treasury Shares is -$9.0 million (2023), against an average of -$5.4 million.
- The widest YoY moves for Treasury Shares: up 5.02% in 2022, down 1.72% in 2022.
- A 5-year view of Treasury Shares shows it stood at $61.8 million in 2022, then gained by 3.21% to $63.8 million in 2023, then grew by 2.47% to $65.3 million in 2024, then climbed by 3.11% to $67.4 million in 2025, then rose by 2.5% to $69.0 million in 2026.
- According to Business Quant data, Treasury Shares over the past three periods registered $69.0 million, $67.4 million, and $67.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 3.01 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 76.26 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 10.61 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | - |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 1.11 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | - |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 3.94 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | -47.00 Mn |
| 10 | Amarin Corp Plcuk | 5.17 Bn | 5.00 Bn | 17.77 Mn | 15.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.95 Mn |
| Mar 31, 2026 | 15.95 Mn |
| Mar 31, 2026 | 69.05 Mn |
| Mar 31, 2026 | 69.05 Mn |
| Dec 31, 2025 | 67.36 Mn |
| Dec 31, 2025 | 13.63 Mn |
| Dec 31, 2025 | 67.36 Mn |
| Dec 31, 2025 | 13.63 Mn |
| Sep 30, 2025 | 13.63 Mn |
| Sep 30, 2025 | 67.36 Mn |
| Sep 30, 2025 | 67.36 Mn |
| Sep 30, 2025 | 13.63 Mn |
| Jun 30, 2025 | 67.11 Mn |
| Jun 30, 2025 | -13.31 Mn |
| Jun 30, 2025 | -13.31 Mn |
| Jun 30, 2025 | 67.11 Mn |
| Mar 31, 2025 | -12.48 Mn |
| Mar 31, 2025 | 66.45 Mn |
| Mar 31, 2025 | 66.45 Mn |
| Mar 31, 2025 | -12.48 Mn |